PCSK9 and Hypercholesterolemia: This occurred despite similarly increased cholesterol levels in WT and ECKO mice (SI Figure 11), although AAV-PCSK9 induced hypercholesterolemia and plaque development was generally reduced at late timepoints, as previously observed (SI Figure 10,11).